HEALTH● LOWJul 31 · Jul 31, 2026, 5:09 PM
Pfizer Drug Restores Pigment in Late-Stage Vitiligo Trials
Human Progress
“Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials… The U.S. drugmaker was testing Litfulo in patients with nonsegmental vitiligo, the most common type of the disease, which causes patches of skin to lose pigment. Pfizer said both studies showed significantly […] The post Pfizer Drug Restores Pigment in Late-Stage Vitiligo Trials appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH56m agoNigerian student dies after asthma attack while celebrating birthday with friends in LondonVanguard NigeriaHEALTH1h agoUnderstanding Your Milk Options: A Dietitian’s Guide to Choosing the Right MilkVanguard NigeriaHEALTH1h agoLouie Shum’s death: heart disease in Hong Kong and what to do in an emergencySouth China Morning PostHEALTH1h agoIs Diet Soda Bad for You ? A Dietitian Breaks Down the Researchprevention.com · United States